Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts now | SmellMyFinger | investorshub | 01/17/2024 9:04:35 PM |
Anyone hear anything lately? Want to see this one go | DawgTrading | investorshub | 01/17/2024 2:36:26 PM |
$NRBO The now | SmellMyFinger | investorshub | 01/17/2024 12:24:51 AM |
got some short data | Arnold25764 | investorshub | 01/16/2024 8:35:01 PM |
Price trading | Invest-in-America | investorshub | 01/16/2024 2:29:43 PM |
$NRBO The now | tw0122 | investorshub | 01/16/2024 1:51:57 PM |
$NRBO Long and strong lets hope im right | tw0122 | investorshub | 01/15/2024 10:29:35 PM |
MomentumIts gaining last up | SmellMyFinger | investorshub | 01/15/2024 6:35:29 PM |
$NRBO short data if anyone is interested | BesaoT35 | investorshub | 01/15/2024 6:04:53 PM |
Price gaining | Arnold25764 | investorshub | 01/15/2024 3:35:12 PM |
what do you make of this data? | BesaoT35 | investorshub | 01/15/2024 3:26:14 PM |
$NRBO short squeeze signal | gr8investment | investorshub | 01/15/2024 1:30:39 PM |
$NRBO The trading last up | BJ-Trader | investorshub | 01/15/2024 6:27:37 AM |
short data if anyone is interested | Arnold25764 | investorshub | 01/15/2024 12:44:20 AM |
$NRBO what does this mean? | SmellMyFinger | investorshub | 01/15/2024 12:02:19 AM |
$NRBO short squeeze article | BesaoT35 | investorshub | 01/14/2024 10:36:47 PM |
$NRBO short data if anyone is interested | PennyPusher786 | investorshub | 01/14/2024 9:39:29 PM |
$NRBO MomentumIts gaining | gr8investment | investorshub | 01/14/2024 8:19:38 PM |
$NRBO should we be shorting? | SmellMyFinger | investorshub | 01/14/2024 7:53:37 PM |
MomentumIts gaining | SmellMyFinger | investorshub | 01/14/2024 7:01:12 PM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...